Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results

Last Modified: 12/14/2008 First Published: 3/24/2004


1.		Phase II Randomized Study of Celecoxib in Patients With Cervical Intraepithelial Neoplasia (CIN) 2/3 or 3

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention, Treatment				Active				18 and over				NCI				GOG-0207 NCT00081263

Last Modified: 10/31/2008 First Published: 3/13/2006


2.		Phase II Randomized Study of Green Tea Extract (Polyphenon E®) for the Prevention of Cervical Cancer in Patients With Human Papillomavirus (HPV) and Low-Grade Cervical Intraepithelial Neoplasia (CIN 1)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Active				18 and over				NCI				UARIZ-UAZ03-1-02 UARIZ-HSC-0540, UAZ03-1-02, NCT00303823

Last Modified: 6/25/2008 First Published: 6/19/2008


3.		Phase II Study of Folic Acid Supplementation in Women Infected With HPV-16 and Diagnosed With Grade 1 or Less Cervical Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Active				19 and over				NCI				UAB-F060511015 F060511015, UAB-IRB0000196, NCT00703196

First Published: 11/6/2008


4.		Phase I Study of pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine and TA-HPV Vaccine With or Without Imiquimod in Patients With Human Papillomavirus 16-Positive Grade 3 Cervical Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention, Treatment				Active				18 and over				NCI				JHOC-J0656 J0656, NA_00002176, NCT00788164

Last Modified: 1/14/2009 First Published: 11/24/2008


5.		Phase I Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Positive and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				12 to 26				NCI				NCI-09-C-0024 09-C-0024, NCI-P07277, NCT00798265

Last Modified: 9/3/2008 First Published: 1/13/2006


6.		Randomized Pilot Study of Zoledronate in Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention, Treatment				Active				18 and over				NCI				UCSF-03421 UCSF-H7810-25693-01, UCSF-H7810-25693-02A, NCT00278434

Last Modified: 9/15/2008 First Published: 4/23/2008


7.		Randomized Study of Health Education Counseling With Versus Without Bupropion Hydrochloride in African-Americans Who Are Light Smokers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training, Prevention				Active				18 and over				NCI				KUMC-HSC-10332 10332, KUMC-070313, NCT00666978

First Published: 4/24/2008


8.		Pilot Study of the Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Virus-Like-Particle Recombinant Vaccine in HIV-Positive Women in India

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Prevention				Approved-not yet active				18 and over				NCI				AMC-054 AMC-054, NCT00667563

Select All on One Page